Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G CHRISTENSEN

Showing results (461-470 of 608) with videos related to

Pageof 61
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 30, 2002
SU6668 inhibits Flk-1/KDR and PDGFRbeta in vivo, resulting in rapid apoptosis of tumor vasculature and tumor regression in miceA Douglas Laird, Jmes G Christensen, Guangmin Li, et al.
The Journal of Physiology|February 2, 2019
Cardiomyocyte substructure reverts to an immature phenotype during heart failureD B Lipsett, M Frisk, J M Aronsen, et al.
Mbio|April 11, 2019
Correction for Christensen et al., "Identification of Novel Protein Lysine Acetyltransferases in Escherichia coli"David G Christensen, Jesse G Meyer, Jackson T Baumgartner, et al.
Molecular Cancer Therapeutics|December 20, 2007
Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphomaJames G Christensen, Helen Y Zou, Maria E Arango, et al.
Research and Practice in Thrombosis and Haemostasis|March 6, 2023
Inter-α-inhibitor heavy chain H4 and sepsis-related coagulation disturbances: Another link between innate immunity and coagulationJulie Brogaard Larsen, Rasmus Pihl, Mathies Appel Aggerbeck, et al.
Neurological Research|March 28, 2012
The addition of Sunitinib to radiation delays tumor growth in a murine model of glioblastomaRandy D'Amico, Liang Lei, Benjamin C Kennedy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
High levels of HER-2 expression alter the ability of epidermal growth factor receptor (EGFR) family tyrosine kinase inhibitors to inhibit EGFR phosphorylation in vivoJ G Christensen, R E Schreck, E Chan, et al.
Cancer Research|November 23, 2012
Resistance to irreversible EGF receptor tyrosine kinase inhibitors through a multistep mechanism involving the IGF1R pathwayAlexis B Cortot, Claire E Repellin, Takeshi Shimamura, et al.
Journal of Pediatric Surgery|August 7, 2025
Surgical management of paediatric appendiceal neuroendocrine tumors: A 26-year Danish nationwide retrospective cohort studySteffanie L T Jensen, Sara Giovannoni, Mona P Ankerstjerne, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2011
Differential (18)F-FDG and 3'-deoxy-3'-(18)F-fluorothymidine PET responses to pharmacologic inhibition of the c-MET receptor in preclinical tumor modelsCarleen Cullinane, Donna S Dorow, Susan Jackson, et al.
Pageof 61

Showing results (461-470 of 608) with videos related to

Sort By:
Pageof 61
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 30, 2002
SU6668 inhibits Flk-1/KDR and PDGFRbeta in vivo, resulting in rapid apoptosis of tumor vasculature and tumor regression in miceA Douglas Laird, Jmes G Christensen, Guangmin Li, et al.
The Journal of Physiology|February 2, 2019
Cardiomyocyte substructure reverts to an immature phenotype during heart failureD B Lipsett, M Frisk, J M Aronsen, et al.
Mbio|April 11, 2019
Correction for Christensen et al., "Identification of Novel Protein Lysine Acetyltransferases in Escherichia coli"David G Christensen, Jesse G Meyer, Jackson T Baumgartner, et al.
Molecular Cancer Therapeutics|December 20, 2007
Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphomaJames G Christensen, Helen Y Zou, Maria E Arango, et al.
Research and Practice in Thrombosis and Haemostasis|March 6, 2023
Inter-α-inhibitor heavy chain H4 and sepsis-related coagulation disturbances: Another link between innate immunity and coagulationJulie Brogaard Larsen, Rasmus Pihl, Mathies Appel Aggerbeck, et al.
Neurological Research|March 28, 2012
The addition of Sunitinib to radiation delays tumor growth in a murine model of glioblastomaRandy D'Amico, Liang Lei, Benjamin C Kennedy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
High levels of HER-2 expression alter the ability of epidermal growth factor receptor (EGFR) family tyrosine kinase inhibitors to inhibit EGFR phosphorylation in vivoJ G Christensen, R E Schreck, E Chan, et al.
Cancer Research|November 23, 2012
Resistance to irreversible EGF receptor tyrosine kinase inhibitors through a multistep mechanism involving the IGF1R pathwayAlexis B Cortot, Claire E Repellin, Takeshi Shimamura, et al.
Journal of Pediatric Surgery|August 7, 2025
Surgical management of paediatric appendiceal neuroendocrine tumors: A 26-year Danish nationwide retrospective cohort studySteffanie L T Jensen, Sara Giovannoni, Mona P Ankerstjerne, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2011
Differential (18)F-FDG and 3'-deoxy-3'-(18)F-fluorothymidine PET responses to pharmacologic inhibition of the c-MET receptor in preclinical tumor modelsCarleen Cullinane, Donna S Dorow, Susan Jackson, et al.
Pageof 61